Mission & Vision
We’re advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.
Our CEO Brent Vaughan’s recent fireside chat at the CNS Summit about game-changing neurotech to improve human cognition.

Our Novel Platform
Introducing our novel platform for neurodegenerative disease
Our investigational medical device delivers non-invasive neuromodulation with the potential to improve outcomes in a range of neurodegenerative diseases, including Alzheimer’s disease.

Our Pipeline
Leveraging our platform across multiple neurodegenerative diseases.
Focus
CogTx-001
Alzheimer’s Disease
CogTx-002
MCI - Alzheimer’s Disease
CogTx-003
Parkinson’s Disease - Dementia
CogTx-004
Multiple Sclerosis
CogTx-005
Ischemic Stroke
Discovery
Preclinical
Early Clinical
Pivotal Clinical
In market
Latest News & Updates
Stay up to date


Dec 1, 2022
Startup’s Headset to Treat Alzheimer’s Will Undergo Wide Trial With Patients


Aug 3, 2022
Cognito's light-and-sound therapy slows brain tissue atrophy in Alzheimer's study


May 2, 2022
Some health apps are able not just to diagnose diseases, but also to treat them


Apr 13, 2022